Skip to Main Content

Try STAT+ TODAY

Pharmalot

Taking stock of the drug industry, from the lab to the medicine chest. Sign up for the newsletter here.

Most Read

Pharmalot Ed Silverman

STAT Plus: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure

Pharmalot Ed Silverman

STAT Plus: Veterans Health Administration will cover the newest Alzheimer’s drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap

Pharmalot Ed Silverman

STAT Plus: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn

Pharmalot Ed Silverman

STAT Plus: Controversial drug for premature birth is withdrawn by manufacturer after battle with FDA

All Coverage

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge

Pharmalot Ed Silverman

STAT Plus: U.K. trade group suspends Novo Nordisk for ‘serious breaches’ in promoting obesity drug

advertisement

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill

Pharmalot Ed Silverman

STAT Plus: Democratic lawmakers press pharmacy chains on abortion pill access

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Novo to cut some insulin prices by up to 75%; Veterans Administration to cover new Alzheimer’s treatment

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pharmacies are battlegrounds in the abortion debate; Lilly Alzheimer’s drug failed to prevent memory loss in study

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden proposes expanding Medicare drug-price negotiation; Weight Watchers moves into obesity drug market

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Walgreens won’t dispense abortion pills in several states; Lilly avoids paying Medicaid rebates with insulin price cuts

Pharmalot Ed Silverman

STAT Plus: As a U.S. agency denies permits to import monkeys for research, industry starts pushing back

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: FDA cites Cipla for placing important manufacturing records in the trash

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: How Lilly’s cuts will affect other efforts to lower insulin prices; pharma rebukes U.K. over clawbacks

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA panel backs a GSK vaccine for RSV; opioid wholesalers cleared of liability to Georgia families

Pharmalot Ed Silverman

STAT Plus: Medicare Part D plans authorized opioid prescriptions for cancer pain — to people without cancer

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Eli Lilly cuts prices for some insulin products; congressional committee opens probe into PBMs

Pharmalot Matthew Herper and Ed Silverman

Eli Lilly cuts prices for some insulin products, but some are wary

Pharmalot Damian Garde

STAT Plus: Pharmalittle: India sends two pharma execs to prison; FDA’s neurology boss departs

Pharmalot Ed Silverman

STAT Plus: FDA is petitioned to boost enforcement of trial sponsors that fail to register studies or report results

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer in talks to acquire Seagen; U.S. trade rep urged not to sanction countries that sidestep Vertex patents

Pharmalot Ed Silverman

STAT Plus: U.S. trade rep urged not to sanction countries if they sidestep patents on Vertex cystic fibrosis drugs

Pharmalot Ed Silverman

STAT Plus: A dozen states sue the FDA in hopes of easing abortion pill restrictions

Pharmalot Ed Silverman

STAT Plus: Little transparency, lots of waste: NIH funds pediatric research, but many trials results go unpublished

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Moderna pays NIH for Covid vaccine technique; first trial over Zantac cancer claims is postponed

Pharmalot Ed Silverman

STAT Plus: Canadian drug price board member resigns over government failure ‘to support real change’

Pharmalot Ed Silverman

STAT Plus: Lawmakers urge U.S. patent office to scrutinize Merck over ‘abuse’ of the system